Medicare Enrolled

Dr. Daniel Rosenbaum, M.D.

Internal Medicine · Willingboro, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
218C SUNSET RD, Willingboro, NJ 08046
6098770400
Registered in NPPES since 2005
NPI: 1073515706 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rosenbaum from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rosenbaum? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rosenbaum

Dr. Daniel Rosenbaum is an internal medicine specialist in Willingboro, NJ, with 21 years of NPI registration. Based on federal Medicare data, Dr. Rosenbaum performed 949 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Rosenbaum received a total of $6,639 from 53 pharmaceutical and/or device companies across 255 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rosenbaum is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 21 years of NPI registration ▲ Top 49% volume in NJ $6,639 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
949
Medicare services
Top 49% in NJ for internal medicine
Not available
Unique patients (not deduplicated)
$90
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
772 $94 $400
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
47 $64 $308
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
36 $65 $233
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
22 $29 $121
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
21 $108 $529
Blood glucose test using hand-held instrument
A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels.
18 $3 $11
New patient office visit, complex (60-74 min) 18 $161 $662
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
15 $89 $450
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,639
Total received (2018-2024)
Avg $948/year across 7 years
Top 12% in NJ for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
255
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,636
2023
$1,217
2022
$933
2021
$326
2020
$302
2019
$1,420
2018
$804

Payments by company (2024)

Abbott Laboratories
$483
Novo Nordisk Inc
$267
Insulet Corporation
$91
Lilly USA, LLC
$83
Amgen Inc.
$76
Mannkind Corporation
$67
Corcept Therapeutics
$62
CeQur Corporation
$62
SANOFI-AVENTIS U.S. LLC
$49
Novartis Pharmaceuticals Corporation
$43
Antares Pharma, Inc.
$38
Janssen Biotech, Inc.
$33
Boehringer Ingelheim Pharmaceuticals, Inc.
$32
Xeris Pharmaceuticals, Inc.
$32
Takeda Pharmaceuticals U.S.A., Inc.
$31
Merck Sharp & Dohme LLC
$31
ABBVIE INC.
$29
Verity Pharmaceuticals Inc.
$27
Bayer Healthcare Pharmaceuticals Inc.
$18
Janssen Pharmaceuticals, Inc
$18
Ardelyx, Inc.
$17
IBSA Pharma Inc.
$17
Rhythm Pharmaceuticals, Inc.
$15
Ascendis Pharma Inc
$14
Top 3 companies account for 51.4% of 2024 payments
All-time payments by company (2018-2024) ›
Abbott Laboratories
$1,105
Novo Nordisk Inc
$751
Insulet Corporation
$431
Valeritas, Inc.
$305
SANOFI-AVENTIS U.S. LLC
$298
Lilly USA, LLC
$284
Horizon Therapeutics plc
$245
Bayer HealthCare Pharmaceuticals Inc.
$236
AbbVie, Inc.
$200
AstraZeneca Pharmaceuticals LP
$199
Dexcom, Inc.
$192
Medtronic MiniMed, Inc.
$148
Amgen Inc.
$142
Bayer Healthcare Pharmaceuticals Inc.
$136
Corcept Therapeutics
$132
Exelixis Inc.
$118
Janssen Pharmaceuticals, Inc
$107
Alexion Pharmaceuticals, Inc.
$106
Merck Sharp & Dohme LLC
$102
Vertiflex, Inc.
$100
Xeris Pharmaceuticals, Inc.
$99
CeQur Corporation
$92
Shire North American Group Inc
$85
Boehringer Ingelheim Pharmaceuticals, Inc.
$72
Becton, Dickinson and Company
$71
Antares Pharma, Inc.
$68
Mannkind Corporation
$67
Merck Sharp & Dohme Corporation
$62
DEXCOM, INC.
$60
Novartis Pharmaceuticals Corporation
$57
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$44
W. L. Gore & Associates, Inc.
$35
Janssen Biotech, Inc.
$33
Amryt Pharma Holdings Ltd
$32
IBSA Pharma Inc.
$32
Takeda Pharmaceuticals U.S.A., Inc.
$31
Medtronic, Inc.
$30
Amneal Pharmaceuticals LLC
$29
ABBVIE INC.
$29
Senseonics, Incorporated
$29
Ascendis Pharma Inc
$27
Companion Medical, Inc.
$27
Verity Pharmaceuticals Inc.
$27
Supernus Pharmaceuticals, Inc.
$22
Edwards Lifesciences Corporation
$22
Embecta Corp.
$19
Ardelyx, Inc.
$17
Rhythm Pharmaceuticals, Inc.
$15
GENZYME CORPORATION
$15
MannKind Corporation
$15
AbbVie Inc.
$14
Regeneron Healthcare Solutions, Inc.
$12
Shionogi Inc
$12
Top 3 companies account for 34.4% of all-time payments
Associated products mentioned in payments ›
AFREZZA · BAQSIMI · BASAGLAR · BD NANO · BD Nano · BD Nano 2nd Gen Pen Needle · BOTOX · BYDUREON · Cabometyx · CeQur Simplicity · ClearSight System · Corlanor · DEXCOM CGM · DEXCOM G6 TRANSMITTER · DIABETES - DISEASE · DUPIXENT · Dexcom G6 Transmitter · ENTRESTO · ENTYVIO · EVENITY · Eversense · FARXIGA · FREESTYLE INSULINX · FREESTYLE LIBRE · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre Pro · FreeStyle Libre blood glucose Flash Monitoring System · GORE CARDIOFORM Septal Occluder · GVOKE HYPOPEN · HUMULIN · IBSRELA · IMCIVREE · INVOKANA · InPen · JANUVIA · JARDIANCE · Kerendia · Korlym · LEQVIO · MINIMED 770G · MINIMED 780G · MOUNJARO · MYCAPSSA · Macrilen · Minimed 630G · Minimed 670G System · Mulpleta · NATPARA · NATPARA (PARATHYROID HORMONE) · NOCDURNA · Omnipod · Ozempic · PRALUENT ALIROCUMAB INJECTION · RECORLEV · RYBELSUS · Repatha · Rybelsus · SOLIQUA 100/33 · STEGLATRO · Superion ISS · Synthroid · TEPEZZA · TOUJEO · TRADJENTA · TREMFYA · TRULICITY · TZIELD · Tirosint · Tlando · Tresiba · UNITHROID · V-GO · VERQUVO · Victoza · Wegovy · XARELTO · XIFAXAN · XYOSTED
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an internal medicine specialist in Willingboro?
Compare internal medicine physicians in the Willingboro area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians in nearby ZIP areas
4,153
County median income
$105,271
Nearest hospital to ZIP centroid (approximate)
VIRTUA WILLINGBORO HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Rosenbaum is a clinical cardiology specialist, with moderate Medicare volume, with 21 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Rosenbaum experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Rosenbaum performed 772 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Rosenbaum receive payments from pharmaceutical companies?
Yes. Dr. Rosenbaum received a total of $6,639 from 53 companies across 255 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rosenbaum's costs compare to other internal medicine physicians in Willingboro?
Dr. Rosenbaum's average Medicare payment per service is $90. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rosenbaum) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →